RetinAI Medical and Retina Consultants of America have partnered to build an artificial intelligence-driven real-world evidence database, according to a press release.
The U.S.-based database will combine information from Retina Consultants of America’s (RCA) 1.7 million patient visits across 200 nationwide locations with insights from RetinAI’s Discovery platform for biomarker analysis and predictive disease analytics.
“Through this partnership with RCA, we are revolutionizing the efficiency and robustness of making decisions around patient care, with an unprecedented scale